首页> 外文会议>2015 1st Workshop on Nanotechnology in Instrumentation and Measurement >Polymethylmethacrylate Nanoparticles as Vehicle for a Molecular Beacon Specific for Survivin mRNA in A549 Cells
【24h】

Polymethylmethacrylate Nanoparticles as Vehicle for a Molecular Beacon Specific for Survivin mRNA in A549 Cells

机译:聚甲基丙烯酸甲酯纳米颗粒作为媒介物对A549细胞中Survivin mRNA特异的分子信标

获取原文
获取原文并翻译 | 示例

摘要

The use of antisense oligonucleotide molecular beacons, able to generate a fluorescent signal when they hybridize with their target mRNA, represents an innovative strategy in cancer. This approach is able to conjugate the ability of sensing specific mRNA with the pharmacological silencing activity, preventing the overexpression of proteins associated to cancer development. In this context, this strategy minimizes the non-specific toxicity addressing the therapy mainly towards the tumor cells by using effective delivery systems. The aim of this work was to investigate the ability of polymethylmethacrylate nanoparticles (PMMA-NPs) to act as vehicle of an oligonucleotide molecular beacon (MB) targeting survivin mRNA in A549 human lung adenocarcinoma epithelial cells. Furthermore, this paper focuses the attention on the need for having an appropriate healthy control in in-vitro experiments. In particular, the survivin-MB was firstly characterized in solution in order to verify its functionality and then the PMMA-NPs ability to promote the MB internalization was verified in A549 cells by confocal microscopy. Confluent Human Dermal Fibroblasts from adult (HDFa) were used as healthy control. The results showed that PMMA-NPs promote the survivin-MB cellular up-take and that the use of 10 μg/mL PMMA-NPs as carrier for survivin-MB for 1h 30 min might be a promising strategy to reduce cancer cell proliferation avoiding detectable consequences on the healthy cells.
机译:当反义寡核苷酸分子信标与其靶mRNA杂交时,能够产生荧光信号的反义寡核苷酸分子的使用代表了癌症的一种创新策略。这种方法能够使特定mRNA的检测能力与药理学沉默活性相结合,从而防止与癌症发展相关的蛋白质过表达。在这种情况下,该策略通过使用有效的递送系统使针对治疗主要针对肿瘤细胞的非特异性毒性最小化。这项工作的目的是研究聚甲基丙烯酸甲酯纳米颗粒(PMMA-NPs)在A549人肺腺癌上皮细胞中充当靶向survivin mRNA的寡核苷酸分子信标(MB)载体的能力。此外,本文将注意力集中在体外实验中对适当健康对照的需求上。具体而言,首先在溶液中表征survivin-MB以验证其功能性,然后通过共聚焦显微镜在A549细胞中验证PMMA-NPs促进MB内在化的能力。来自成人的融合人皮肤成纤维细胞(HDFa)被用作健康对照。结果表明,PMMA-NPs促进survivin-MB细胞摄取,使用10μg/ mL PMMA-NPs作为survivin-MB的载体持续1h 30 min可能是减少癌细胞增殖,避免检测的有前途的策略。对健康细胞的后果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号